A pharma client launching in a competitive therapy area partnered with IQVIA to better identify and engage key opinion leaders (KOLs) and digital opinion leaders (DOLs). Using claims data, social media insights, and real-time science alerts, IQVIA provided targeted profiling and monitoring. To measure impact, the client adopted IQVIA’s Share of Scientific Voice (SoSV), tracking mentions in publications and conferences versus competitors. Results included saving each medical science liaison 4–6 hours weekly (about $2.5M annually), prioritizing the most relevant KOLs, and significantly boosting share of voice in scientific forums.

Join for free to read